-
CytoDyn Appoints Seenu Srinivasan as Executive Director of CMC Regulatory Affairs
firstwordpharma
August 27, 2021
CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company") announced today the appointment of Seenu Srinivasan, Ph.D., as Executive Director-CMC Regulatory Affairs.
-
Frontage Opens New Lab Facility in Exton, PA
contractpharma
August 10, 2021
Frontage Laboratories, Inc. completed construction of a new 71,000 sq.-ft. laboratory facility in Exton, PA.
-
ImmVira Launches Pilot-scale Production Line to Expedite the Advancement of Next-generation OV Clinical Trials
prnasia
July 19, 2021
On July 18, 2021, ImmVira inaugurated a pilot-scale production line in Shenzhen and officially initiated its in-house production of our next-generation oncolytic viruses (OV) used for IND applications and Phase I/II clinical trials.
-
CatSci Opens New Dagenham Laboratory
contractpharma
June 10, 2021
New facility is equipped with state-of-the-art analytical equipment through a collaboration with Shimadzu Corporation.
-
LINK Medical Expands its Regulatory Services Team, Strengthening its IMPD & CMC Capabilities
PharmaSources
May 06, 2021
LINK Medical expands its regulatory services team, strengthening its IMPD & CMC capabilities.
-
TCG Lifesciences Expands Footprint to the U.S.
contractpharma
February 09, 2021
TCG Lifesciences Pvt. Ltd., a company controlled by New York-based The Chatterjee Group, has expanded its operations in the U.S. with the establishment of TCG GreenChem Inc., a subsidiary of TCG Lifesciences to provide contract development and ...
-
Passage Bio Invests in Gene Therapy Manufacturing R&D Site
contractpharma
December 18, 2020
In combination with dedicated cGMP suite at Catalent, the new lab creates foundation for integrated AAV gene therapy manufacturing.
-
Parexel Launches COVID-19 Risk Mitigation Offering
contractpharma
May 14, 2020
Four-step methodology aims ensure manufacturers can safely continue manufacturing operations through the COVID-19 pandemic.
-
CMC Pharmaceuticals Launches cGMP Lab Services
contractpharma
September 18, 2019
Addition includes the upgrading of laboratory SOPs and documentation practices to comply with U.S. FDA guidelines.
-
Great Bay Bio Adds Two Industry leaders to Advisory board
biospectrumasia
August 15, 2019
he board of directors eagerly welcome two top industry elites, Dr Katie Su and Mr Aaron Wang, to the company with the establishment of its 3D Advisory Board